Your CDMO specialized in lentiviral vectors

Making the medicine of the future a reality

Our services

Expertise in virology, we adapt ad-hoc to meet the specific requirements of your lentiviral vector.

Business model

GMP CDMO focused on different stages of the process.

Specialization

We work exclusively in lentivirus, offering comprehensive services.

Customized service

Technical adaptation and timely slot availability for each project.

Quality and safety

Compliance with EMA and FDA regulatory requirements.

Trusted by industry leaders

Vivebiotech in data

+45 customers

in the US, Europe, Asia and Australia

4x greater batch capacity

in reactor since 2020

4x increase in staff

since 2018

7 rooms dedicated

exclusively to lentivirus production

70% hold PhDs or bachelor's degrees

combining young talent and experience

About us

We are a Contract Development and Manufacturing Organization (CDMO) with over 40 biotech companies worldwide that have placed their trust in us.

Read more

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.

Read more
See all news

Last news

23 January 2025

VIVEbiotech wins the CMO/CDMO of the Year Award at the Advanced Therapies Awards

We are overjoyed to announce that VIVEbiotech has been named the “CMO/CDMO of the...

Read more

18 March 2025

VIVEbiotech at Advanced Therapies 2025: connect with our team in London

Meet Natalia Elizalde, our dedicated representative, and explore how we can support your advanced therapies...

Read more

With the support of